+25.5%
GSK vs SIMO
+235.9%
-210.4%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SIMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | +6.2% | -8.9% | -2.4% |
| 7D | -4.2% | +14.6% | -18.8% | -3.5% |
| 30D | -7.5% | +6.2% | -13.7% | -7.1% |
| 3M | -3.3% | +3.6% | -6.8% | -2.6% |
| 6M | -9.3% | +130.8% | -140.1% | -7.1% |
| YTD | +1.6% | +195.8% | -194.2% | +2.5% |
| 1Y | +25.5% | +225.0% | -199.5% | +23.6% |
| All | +25.5% | +235.9% | -210.4% | +23.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SIMO.
Daily Out/Under-Performance
Portfolio return minus SIMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SIMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SIMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling